Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Revenue
Others
Ratios

Trinity Biotech (TRIB) EPS (Weighted Average and Diluted) (2021 - 2022)

Historic EPS (Weighted Average and Diluted) for Trinity Biotech (TRIB) over the last 2 years, with Q2 2022 value amounting to -$53.6 million.

  • Trinity Biotech's EPS (Weighted Average and Diluted) fell 50663.14% to -$53.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was -$53.6 million, marking a year-over-year decrease of 50663.14%. This contributed to the annual value of -$1.77 for FY2024, which is 4363.06% up from last year.
  • Trinity Biotech's EPS (Weighted Average and Diluted) amounted to -$53.6 million in Q2 2022, which was down 50663.14% from $13.2 million recorded in Q2 2021.
  • Trinity Biotech's EPS (Weighted Average and Diluted)'s 5-year high stood at $13.2 million during Q2 2021, with a 5-year trough of -$53.6 million in Q2 2022.